High expression of TAZ indicates a poor prognosis in retinoblastoma

BACKGROUND: The transcriptional co-activator, TAZ, is an important effector of the Hippo pathway and is critical for the development of human cancers. However, the expression and prognostic significance of TAZ in retinoblastoma is currently unclear. METHODS: TAZ expression was examined in 43 retinob...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yiting, Xue, Chunyan, Cui, Hongjuan, Huang, Zhenping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605227/
https://www.ncbi.nlm.nih.gov/pubmed/26464030
http://dx.doi.org/10.1186/s13000-015-0415-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605227/
https://www.ncbi.nlm.nih.gov/pubmed/26464030
http://dx.doi.org/10.1186/s13000-015-0415-9

Ejemplares similares